Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

1.86
Delayed Data
As of 12:36pm ET
 -0.0299 / -1.58%
Today’s Change
1.74
Today|||52-Week Range
10.60
-41.57%
Year-to-Date
3 Companies That Probably Won't Survive Till 2019
Mar 13 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close1.89
Today’s open1.84
Day’s range1.80 - 1.87
Volume505,004
Average volume (3 months)1,107,693
Market cap$181.0M
Dividend yield--
Data as of 12:36pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-163.97%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio1.4
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FBIOFortress Biotech Inc+0.22+6.11%
RDHLRedhill Biopharma Lt...-0.07-0.67%
CLSDClearside Biomedical...+0.15+2.05%
KURAKura Oncology Inc-0.10-1.16%
Data as of 12:37pm ET, 03/27/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts


Search for Jobs